Regulation, Compliance & Legal › Sub-category

Governance Issue

8 articles
Corporate governance challenges are emerging across various Indian sectors, signaling potential investor caution. Several companies, including Mega Fin and DCM Shriram Fine Chemicals, reported net losses in the September 2026 quarter, with Mega Fin facing an auditor's emphasis of matter regarding its going concern. Simultaneously, the Reserve Bank of India extended the supersession of Abhyudaya Co-operative Bank's board due to ongoing governance concerns, while other firms like Parmax Pharma are undergoing significant structural changes, including office relocations and internal audit appointments. These developments highlight the importance of scrutinizing corporate oversight and financial health, particularly for companies navigating challenging economic conditions.
Strides Pharma Appoints Biren Gabhawala Independent Director
Strides Pharma seeks shareholder approval via postal ballot for appointing Biren Gabhawala as an Independent Director for a five-year term. The e-voting period runs from November 19 to December 19, 20
Dr. Rajesh Sharma Appointed NCVET Executive Member
Dr. Rajesh Sharma appointed as Executive Member of the National Council for Vocational Education and Training (NCVET). He brings over 35 years of leadership experience in ICT, public policy, innovatio
Sammaan Capital Q2 FY27 PAT Rises 28% QoQ
Sammaan Capital reported Q2 FY27 PAT of INR312 crore, up 28% QoQ, with AUM at INR59,188 crore and gross NPA improving to 0.15%. IHC converted first warrant tranche, investing INR906 crore to raise sta
Aban Offshore 40th AGM E-Voting Results
Aban Offshore Limited discloses e-voting results for its 40th AGM held virtually on November 16, 2026. Both resolutions passed with near-unanimous approval: adoption of FY26 financial statements and r
Aban Offshore 40th AGM Approves FY26 Financial Statements
Aban Offshore held its 40th AGM on November 16, 2026, adopting FY26 audited financial statements and re-appointing a director. The meeting noted corrections to borrowings figures in the balance sheet:
Oil India Announces SEBI Demat Window for Shareholders
Oil India Limited published an advertisement on November 16, 2026, informing shareholders about SEBI's special window for physical securities dematerialisation. Hindustan Unilever Limited initiated a
Parmax Pharma Board Adjourns Q2 Results, Approves Office Shift
Board adjourned approval of un-audited Q2 September 2026 financial results without providing new date. Approved shifting registered office from Gujarat to Maharashtra, requiring shareholder and regula
DCM Shriram Fine Chemicals Q2 Net Loss at ₹7.65 Lakh
DCM Shriram Fine Chemicals reported a consolidated net loss of ₹7.65 lakh for Q2 September 2026, with revenue declining to ₹89.97 crore. The Board approved the appointment of Ashwini Shanker as an Ind